Medicamen Biotech Share Price
Know More₹352.10-1.90 (-0.54%)
02:06 PM, 21-Jan-2026₹355.40 1.20 (0.34%)
01:54 PM, 21-Jan-2026BSE : 531146
NSE : MEDICAMEQ
Sector : Health care
ISIN Code : INE646B01010
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 21-Jan-2026 | 02:06 PM IST
| Market Cap (₹ Cr) | 477 |
Traded Value (₹ Cr) | 0.03 |
Volume (Shares) | 832 |
Face Value (₹) | 10 |
52-Week High (₹) | 560.00 |
52-Week High Date | 21-Feb-2025 |
52-Week Low (₹) | 292.50 |
52-Week Low Date | 29-Sep-2025 |
All Time High (₹) | 1,219.00 |
All Time High Date | 01-Sep-2022 |
All Time Low (₹) | 2.25 |
All Time Low Date | 18-Apr-2001 |
Medicamen Biotech Ltd
Medicamen Biotech Ltd News
Medicamen Biotec Announcement
Medicamen Biotech Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 482 |
| EPS - TTM (₹) [C] | 6.26 |
| P/E Ratio (X) [C] | 56.77 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 10.00 |
| Latest Dividend Date | 19-Sep-2025 |
| Dividend Yield (%) | 0.26 |
| Book Value Share (₹) [C] | 203.06 |
| P/B Ratio (₹) [C] | 1.75 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.00 | 76 | 0.02 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 343.50 365.55 |
| Week Low/High (₹) | 343.50 395.00 |
| Month Low/High (₹) | 343.50 407.00 |
| Year Low/High (₹) | 292.95 561.00 |
| All time Low/High (₹) | 2.25 1,225.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -7.81% | -7.84% | -1.74% | -1.94% |
| 1 Month | -10.08% | -10.28% | -3.53% | -3.07% |
| 3 Month | 9.42% | 8.77% | -2.96% | -2.71% |
| 6 Month | -11.57% | -11.60% | -0.33% | 0.31% |
| 1 Year | -27.61% | -27.76% | 8.03% | 9.31% |
| 3 Year | -56.87% | -56.64% | 35.15% | 39.61% |
Company Info
Company Information
Chairman & Non Executive Dir. : Rahul Bishnoi
Non-Exec & Non-Independent Dir : Vimal Kumar Shrawat
Non-Exec & Non-Independent Dir : S K Singh
Non-Exec & Non-Independent Dir : Ashwani Kumar Sharma
Non-Exec & Non-Independent Dir : Sanjay Bansal
Independent Non Exe. Director : Harish Pande
Independent Non Exe. Director : Arun Kumar
Independent Non Exe. Director : Sumita Dwivedi
Independent Non Exe. Director : Sangeeta Bishnoi
Independent Non Exe. Director : Ravi Kumar Bansal
Independent Non Exe. Director : SHAM GOEL
Independent Non Exe. Director : SHAIVAL SAURABH
Company Sec. & Compli. Officer : Parul Choudhary
Registered Office: 1506 Chiranjiv Tower 43, Nehru Place,New Delhi,New Delhi-110019 Ph: 91-11-47589500
Email:cs@medicamen.com
FAQs about Medicamen Biotech Ltd
1. What's the Medicamen Biotech Ltd share price today?
Medicamen Biotech Ltd share price was Rs 352.10 at 02:06 PM IST on 21st Jan 2026. Medicamen Biotech Ltd share price was up by 0.54% over the previous closing price of Rs 354.00. Medicamen Biotech Ltd share price trend:
- Last 1 Month: Medicamen Biotech Ltd share price moved down by 10.08% on BSE.
- Last 3 Months: Medicamen Biotech Ltd share price moved up by 9.42% on BSE.
- Last 12 Months: Medicamen Biotech Ltd share price moved down by 27.61% on BSE.
- Last 3 Years: Medicamen Biotech Ltd share price moved down by 56.87% on BSE.
2. How can I quickly analyse the performance of the Medicamen Biotech Ltd stock?
The performance of the Medicamen Biotech Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 56.77
- Price to book value ratio is 1.75
- Dividend yield of 0.26
- The EPS (trailing 12 months) of the Medicamen Biotech Ltd stock is Rs 6.26
3. What is the market cap of Medicamen Biotech Ltd?
Medicamen Biotech Ltd has a market capitalisation of Rs 477 crore.
4. What is Medicamen Biotech Ltd's 52-week high/low share price?
The Medicamen Biotech Ltd’s 52-week high share price is Rs 560.00 and 52-week low share price is Rs 292.50.
5. Is the Medicamen Biotech Ltd profitable?
On a consolidated basis, Medicamen Biotech Ltd reported a profit of Rs 2.11 crore on a total income of Rs 47.54 crore for the quarter ended 2025.
6. Which are Medicamen Biotech Ltd’s peers in the Health care sector?
Medicamen Biotech Ltd’s top 5 peers in the Health care sector are Wanbury, Kilitch Drugs, Shree Ganesh Rem, Medicamen Biotec, Jenburkt Pharma, Solara Active PP, Everest Organics.
7. Who owns how much in Medicamen Biotech Ltd?
Key changes to the Medicamen Biotech Ltd shareholding are as follows:
- Promoter holding in Medicamen Biotech Ltd has gone up to 40.46 per cent as of Dec 2025 from 40.46 per cent as of Apr 2025.